Paper42940211PubMed
The Translational Value of Preclinical Research: Lessons from More Than Forty Years of Retinal Research.
Bagnoli P. Biomedicines, 2026.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The Translational Value of Preclinical Research: Lessons from More Than Forty Years of Retinal Research. Papers, record 42940211. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42940211
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Translational Value of Preclinical Research: Lessons from More Than Forty Years of Retinal Research.
- Journal
- Biomedicines
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-28
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31374938 | Neuroprotective Peptides in Retinal Disease. | J Clin Med | 2019 | https://conductscience.org/library/papers/31374938 | PubMed |
| 2 | 23434527 | A rapid liquid chromatography tandem mass spectrometry-based method for measuring propranolol on dried blood spots. | J Pharm Biomed Anal | 2013 | https://conductscience.org/library/papers/23434527 | PubMed |
| 3 | 30389750 | Effects of Topically Administered Neuroprotective Drugs in Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial. | Diabetes | 2019 | https://conductscience.org/library/papers/30389750 | PubMed |
| 4 | 9915710 | Di Bella's therapy: the last word? The evidence would be stronger if the researchers had randomised their studies. | BMJ | 1999 | https://conductscience.org/library/papers/9915710 | PubMed |
| 5 | 41919172 | Mirabegron in patients with age-related macular degeneration treated for overactive bladder: a study protocol for a prospective observational non-randomized trial. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/41919172 | PubMed |
| 6 | 42688303 | Novel insights into β3-adrenoceptor function in a model of retinopathy of prematurity: the contribution of astrocytes to retinal protection. | Front Neurosci | 2026 | https://conductscience.org/library/papers/42688303 | PubMed |
| 7 | 40097526 | Study of the efficacy and the mechanism of action of lanreotide for the treatment of persistent diabetic macular edema. | Sci Rep | 2025 | https://conductscience.org/library/papers/40097526 | PubMed |
| 8 | 35986147 | Propranolol ameliorates retinopathy of prematurity in mice by downregulating HIF-1α via the PI3K/Akt/ERK pathway. | Pediatr Res | 2023 | https://conductscience.org/library/papers/35986147 | PubMed |
| 9 | 42459363 | Inhibiting the uPAR/FPR1 interactions reduces blood-retinal barrier breakdown and improves retinal function in a rat model of diabetes. | Front Neurosci | 2026 | https://conductscience.org/library/papers/42459363 | PubMed |
| 10 | 26775688 | Ten years of anti-vascular endothelial growth factor therapy. | Nat Rev Drug Discov | 2016 | https://conductscience.org/library/papers/26775688 | PubMed |
| 11 | 23528535 | Eye drop propranolol administration promotes the recovery of oxygen-induced retinopathy in mice. | Exp Eye Res | 2013 | https://conductscience.org/library/papers/23528535 | PubMed |
| 12 | 14614951 | Genetic deletion of somatostatin receptor 1 alters somatostatinergic transmission in the mouse retina. | Neuropharmacology | 2003 | https://conductscience.org/library/papers/14614951 | PubMed |
| 13 | 20739470 | Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade. | Invest Ophthalmol Vis Sci | 2011 | https://conductscience.org/library/papers/20739470 | PubMed |
| 14 | 31426601 | The uPAR System as a Potential Therapeutic Target in the Diseased Eye. | Cells | 2019 | https://conductscience.org/library/papers/31426601 | PubMed |
| 15 | 39723681 | Neuropeptides: The Evergreen Jack-of-All-Trades in Neuronal Circuit Development and Regulation. | Bioessays | 2025 | https://conductscience.org/library/papers/39723681 | PubMed |
| 16 | 23111729 | Different efficacy of propranolol in mice with oxygen-induced retinopathy: could differential effects of propranolol be related to differences in mouse strains? | Invest Ophthalmol Vis Sci | 2012 | https://conductscience.org/library/papers/23111729 | PubMed |
| 17 | 38227526 | On implications of somatostatin in diabetic retinopathy. | Neural Regen Res | 2024 | https://conductscience.org/library/papers/38227526 | PubMed |
| 18 | 37620616 | Progress in Ocular Drug Delivery: Challenges and Constraints. | Handb Exp Pharmacol | 2024 | https://conductscience.org/library/papers/37620616 | PubMed |
| 19 | 38847896 | Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomes. | Graefes Arch Clin Exp Ophthalmol | 2024 | https://conductscience.org/library/papers/38847896 | PubMed |
| 20 | 39539264 | Turn-Adopting Peptidomimetic as a Formyl Peptide Receptor-1 Antagonist. | ACS Pharmacol Transl Sci | 2024 | https://conductscience.org/library/papers/39539264 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42940211
GET https://conductscience.org/api/papers/v1/42940211/references?page=2